Jeremy Bastid, Chief Development Officer at ORPHELIA Pharma will attend the Advances in Neuroblastoma Research (ANR) meeting to be held May 15-18, 2023 in Amsterdam, the Netherlands.
ANR meetings gather investigators from around the world studying neuroblastoma biology, diagnosis, prognosis, and therapy.
If you would like to arrange a meeting with Jeremy, please contact him at: jeremy.bastid@orphelia-pharma.eu